Here are the local and international drugmakers also eyeing the Indian market and looking to introduce rivals to Lilly's drug ...

Ajanta Pharma Ltd.(down 1.53 per cent), Dr. Reddy's Laboratories Ltd.(down 1.35 per cent), Aurobindo Pharma Ltd.(down 1.0 ...

IST, the barometer index, the S&P BSE Sensex tumbled 328.07 points or 0.43% to 77,689.26. The Nifty 50 index fell 64.30 points or 0.27% to 23,604.35.

ET Intelligence Group: The stock of Aurobindo Pharma has lost 13% in 2025 so far, underperforming the 10% drop in the BSE ...

Telangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment ...

Curateq Biologics, a wholly owned subsidiary of Aurobindo Pharma, has allotted 4,125,055 Compulsory Convertible Preference Shares (CCPSs) of Rs.10/- each to Dr. Satakarni Makkapati on 20 March 2025.

On March 13, 2025, the Federal Circuit issued a decision in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., No. 23-2254 (Fed. Cir. 2025) ...

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and ...

The growth of the India generic drugs market is supported by proactive government policies aimed at bolstering the pharmaceutical sector. Initiatives such as the “Make in India” campaign and ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

The first of the three vaccines is Covaxin, developed jointly by ICMR and Bharat Biotech, a private company. The government ...

Aurobindo Pharma has terminated its licensing agreement with Hilleman Laboratories Singapore for a paediatric pentavalent vaccine candidate, effective March 5, 2025. The company clarifies that the ...